BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27895401)

  • 1. HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.
    Choi Y; Ko YS; Park J; Choi Y; Kim Y; Pyo JS; Jang BG; Hwang DH; Kim WH; Lee BL
    World J Gastroenterol; 2016 Nov; 22(41):9141-9153. PubMed ID: 27895401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu W; Xu Z; Zhang M; Zuo Y
    Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
    Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
    Kim HP; Han SW; Song SH; Jeong EG; Lee MY; Hwang D; Im SA; Bang YJ; Kim TY
    Oncogene; 2014 Jun; 33(25):3334-41. PubMed ID: 23873022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
    Yeh CT; Wu CH; Yen GC
    Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.
    Ye B; Jiang LL; Xu HT; Zhou DW; Li ZS
    Int J Immunopathol Pharmacol; 2012; 25(3):627-36. PubMed ID: 23058013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 expression and PI3K-Akt pathway alterations in gastric cancer.
    Sukawa Y; Yamamoto H; Nosho K; Ito M; Igarashi H; Naito T; Mitsuhashi K; Matsunaga Y; Takahashi T; Mikami M; Adachi Y; Suzuki H; Shinomura Y
    Digestion; 2014; 89(1):12-7. PubMed ID: 24458107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
    Liu Z; Zhu J; Cao H; Ren H; Fang X
    Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Epidermal Growth Factor Receptor-2 Promotes Invasion and Metastasis in Gastric Cancer by Activating Mitogen-activated Protein Kinase Signaling.
    Hou F; Shi DB; Chen YQ; Gao P
    Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):529-534. PubMed ID: 29734245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
    Park J; Choi Y; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Park JW; Lee BL
    Cancer Res Treat; 2018 Jan; 50(1):239-254. PubMed ID: 28343375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
    Ko YS; Cho SJ; Park J; Kim Y; Choi YJ; Pyo JS; Jang BG; Park JW; Kim WH; Lee BL
    Br J Cancer; 2015 Oct; 113(8):1186-96. PubMed ID: 26448177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma.
    Ren HY; Liu F; Huang GL; Liu Y; Shen JX; Zhou P; Liu WM; Shen DY
    Oncotarget; 2017 Jan; 8(4):6718-6729. PubMed ID: 28035062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD; Zuo Y; Xu Z; Zhang M
    World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
    Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
    Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
    Wang F; Ruan L; Yang J; Zhao Q; Wei W
    Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer.
    Zhang Z; Wang J; Ji D; Wang C; Liu R; Wu Z; Liu L; Zhu D; Chang J; Geng R; Xiong L; Fang Q; Li J
    Clin Cancer Res; 2014 Sep; 20(17):4559-73. PubMed ID: 24973425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.